To the Editor We congratulate Wunderink et al1 for their long-term follow up of 7 years of patients with remitted first-episode psychosis. Their results suggest superior rates of social functioning for patients who receive dose reduction/discontinuation compared with maintenance treatment, despite a higher relapse rate during the first 3 years of treatment in the dose reduction/discontinuation group.